Cargando…
Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review
Coronaviruses, which were discovered in 1968, can lead to some human viral disorders, like severe acute respiratory syndrome (SARS), Middle East respiratory syndrome-related (MERS), and, recently, coronavirus disease 2019 (COVID-19). The coronavirus that leads to COVID-19 is rapidly spreading all ov...
Autores principales: | Hosseini-Zare, Maryam S., Thilagavathi, Ramasamy, Selvam, Chelliah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055768/ https://www.ncbi.nlm.nih.gov/pubmed/35519094 http://dx.doi.org/10.1039/d0ra04395h |
Ejemplares similares
-
Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach
por: Palanisamy, Kandhan, et al.
Publicado: (2022) -
Methods of hexagonal boron nitride exfoliation and its functionalization: covalent and non-covalent approaches
por: Gautam, Chandkiram, et al.
Publicado: (2021) -
Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)
por: McFee, R.B.
Publicado: (2020) -
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
por: Tong, Tommy R.
Publicado: (2006) -
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
por: Rajasekharan, Sreejith, et al.
Publicado: (2021)